MedTrace Logo

Clinical Evaluation of a New Aspheric Intraocular Lens.

NCT00786565 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2011-12-12

Study results available
· View outcomes & findings →

Summary

This study evaluates the visual performance and occurrence of posterior capsular opacification after implantation of a new aspherical intraocular lens compared with a control spherical lens of otherwise identical design.

Conditions

  • Cataract

Interventions

DEVICE

Advanced Akreos Adapt in one operated eye.

Cataract surgery to implant the assigned IOL according to randomized schedule.

DEVICE

Akreos Adapt in fellow operated eye.

Cataract surgery to implant the assigned IOL according to randomized schedule.

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00786565 on ClinicalTrials.gov